undefined
EUTM file information

018251946

WUXIA


June 9, 2020

Trademark Summary

The trademark application WUXIA was filed by WUXI BIOLOGICS IRELAND LIMITED, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on July 8, 2020, and it was registered by office on October 16, 2020 without any oppositions.

The application was filed in English (Spanish was selected as the second language).

A transfer of the trademark registration was recorded on January 26, 2022. Change of name and professional address of the trademark registration was recorded on July 5, 2022. Change of name and professional address of the trademark registration was recorded on July 18, 2022.


Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Biological preparations, other than for medical or veterinary purposes
    2. Biological preparations, other than for medical or veterinary purposes, for producing protein
    3. Biological material for producing protein
    4. Cells, vectors and expression systems for producing proteins.
  • The mark was filed in class 5 with following description of goods:
    1. Biological preparations for medical purposes
    2. Biological preparations for medical purposes (production of protein)
    3. Biological material for producing medical protein
    4. Cells, vectors and expression systems for producing medical proteins
    5. Biological preparations for veterinary purposes
    6. Biological preparations for veterinary purposes (production of protein).
  • The mark was filed in class 42 with following description of goods:
    1. Product development for others
    2. Pharmaceutical research and development services
    3. Scientific research and development
    4. Research of pharmaceuticals
    5. Research and development of new products
    6. Consultancy services in the field of technological development
    7. Biochemical research and analysis
    8. Biomedical research services
    9. Development of pharmaceutical preparations and medicines
    10. Research and development services in the field of antibodies
    11. Research and development services in the field of gene expression systems.